Cox proportional hazards modeling of complications
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| Any complication | 10.96 | (3.46, 34.69) | < .0001* |
| Gastrointestinal disease | 2.78 | (1.44, 3.59) | .0004* |
| Liver disease/hepatitis | 2.48 | (1.51, 4.09) | .0003* |
| Lymphoma | 2.44 | (1.43, 4.16) | .0010* |
| Chronic lung disease (structural and functional) | 2.06 | (1.34, 3.16) | .0010* |
| Malabsorption | 2.06 | (1.11, 3.81) | .0218* |
| Splenectomy | 1.69 | (0.91, 3.12) | .0957 |
| Cancer | 1.51 | (0.795, 2.87) | .2084 |
| Autoimmunity | 1.36 | (0.87, 2.12) | .1735 |
| Granuloma | 1.27 | (0.65, 2.48) | .4939 |
| Bronchiectasis | 0.76 | (0.39, 1.48) | .4235 |
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| Any complication | 10.96 | (3.46, 34.69) | < .0001* |
| Gastrointestinal disease | 2.78 | (1.44, 3.59) | .0004* |
| Liver disease/hepatitis | 2.48 | (1.51, 4.09) | .0003* |
| Lymphoma | 2.44 | (1.43, 4.16) | .0010* |
| Chronic lung disease (structural and functional) | 2.06 | (1.34, 3.16) | .0010* |
| Malabsorption | 2.06 | (1.11, 3.81) | .0218* |
| Splenectomy | 1.69 | (0.91, 3.12) | .0957 |
| Cancer | 1.51 | (0.795, 2.87) | .2084 |
| Autoimmunity | 1.36 | (0.87, 2.12) | .1735 |
| Granuloma | 1.27 | (0.65, 2.48) | .4939 |
| Bronchiectasis | 0.76 | (0.39, 1.48) | .4235 |
Adjusted for age at diagnosis.
P value significant at the .05 level.